(EurekAlert!) — Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ischemic stroke, only about 5 percent fully recover. Most others suffer from long-term problems, including weakness, chronic pain, or epilepsy.
Now, scientists at Gladstone Institutes and the regenerative medicine company SanBio have shown that a cell therapy derived from stem cells can restore normal patterns of brain activity after a stroke. While most stroke treatments must be administered in the immediate hours after a stroke to have a benefit, the cell therapy was effective in rats even when given one month later. CONTINUE